HALO

91.3501.82%
DS

Darren Snellgrove

Senior VP & CFO

Mr. Darren Snellgrove is Chief Financial Officer of Halozyme Therapeutics, Inc. from June 8, 2026 and serves as Senior Vice President. He was Vice President of Investor Relations of Johnson & Johnson. Mr. Snellgrove served as Chief Financial Officer of Johnson & Johnson's Pharmaceuticals sector, where he provided global financial leadership. He was Vice President, Finance for Janssen Research & Development. He was Vice President, Finance and Operations for Johnson & Johnson Innovation. He joined Johnson & Johnson through the acquisition of Centocor in 1999, where he spent a number of years in roles of increasing responsibility supporting a variety of functions, including Commercial, R&D and Business Development. Beginning in 2002, he spent three years in J&J’s Mergers and Acquisitions Finance group, providing financial leadership on over 100 potential acquisitions, major licensing deals, equity investments, options, structures and divestitures across all sectors. Prior to joining the Johnson & Johnson Innovation Organization, he was VP of Finance and Procurement, Chief Financial Officer at Janssen AI. He holds a BA Honors degree in Economics and Philosophy from Southampton University in England and an MBA from Villanova University.

Positions